Rosuvastatin + Atorvastatin

Phase 3Completed

0 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Hypercholesteremia

Conditions

Hypercholesteremia

Trial Timeline

Jun 1, 2003 → Feb 1, 2005

NCT ID

NCT00239330

About Rosuvastatin + Atorvastatin

Rosuvastatin + Atorvastatin is a phase 3 stage product being developed by AstraZeneca for Hypercholesteremia. The current trial status is completed. This product is registered under clinical trial identifier NCT00239330. Target conditions include Hypercholesteremia.

What happened to similar drugs?

2 of 4 similar drugs in Hypercholesteremia were approved

Approved (2) Terminated (0) Active (2)

✅atorvastatin, LipitorAstellas PharmaApproved

✅Rosuvastatin + HMG CoA inhibitorShionogiApproved

🔄Rosuvastatin calciumAstraZenecaPhase 3

🔄MK-0524A + ER Niacin + PlaceboMerckPhase 3

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (13)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00683618	Phase 3	Completed	May 1, 2008	Jul 1, 2009	Hypercholesterolemia
NCT00620542	Phase 3	Completed	Jan 1, 2008	Jun 1, 2011	Coronary Atherosclerosis
NCT00427960	Approved	Terminated	Dec 1, 2006	Feb 1, 2008	Hypercholesterolaemia
NCT00395486	Approved	Completed	Sep 1, 2006	Jun 1, 2008	Metabolic Syndrome X
NCT00296400	Phase 2	Completed	Feb 1, 2006	Jun 1, 2009	Hyperlipidemia
NCT00296387	Phase 3	Completed	Jan 1, 2006	Oct 1, 2007	Acute Coronary Syndrome
NCT00329173	Phase 3	Completed	Nov 1, 2003	Aug 1, 2004	Hypercholesterolaemia
NCT00239330	Phase 3	Completed	Jun 1, 2003	Feb 1, 2005	Hypercholesteremia
NCT00653965	Phase 3	Completed	May 1, 2003	Feb 1, 2005	Hypercholesterolemia
NCT00653588	Phase 3	Completed	Apr 1, 2003	Sep 1, 2004	Hypercholesterolemia
NCT00654225	Phase 3	Completed	Oct 1, 2002	Mar 1, 2005	Hypercholesterolemia
NCT00654485	Phase 3	Completed	May 1, 2002	Feb 1, 2005	Metabolic Syndrome
NCT00653744	Phase 3	Completed	Mar 1, 2002	Mar 1, 2004	Hypercholesterolemia

Competing Products

5 competing products in Hypercholesteremia

See all competitors

Product	Company	Stage	Hype Score
atorvastatin, Lipitor	Astellas Pharma	Approved	43
Rosuvastatin + HMG CoA inhibitor	Shionogi	Approved	43
SHR-1209 + Placebo	Jiangsu Hengrui Medicine	Phase 1	29
Rosuvastatin calcium	AstraZeneca	Phase 3	40
MK-0524A + ER Niacin + Placebo	Merck	Phase 3	40